Annovis Bio, Inc.
General ticker "ANVS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $33.4M (TTM average)
Annovis Bio, Inc. follows the US Stock Market performance with the rate: 24.0%.
Estimated limits based on current volatility of 2.4%: low 1.90$, high 2.00$
Factors to consider:
- Total employees count: 6 (+20.0%) as of 2023
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Liquidity and credit risks, Economic downturns and volatility, Third-party risks, Cybersecurity threats, Labor/talent shortage/retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.50$, 4.67$]
- 2026-12-31 to 2027-12-31 estimated range: [1.09$, 3.49$]
Short-term ANVS quotes
Long-term ANVS plot with estimates
Financial data
| YTD | 2025-12-31 |
|---|---|
| Operating Revenue | $0.00MM |
| Operating Expenses | $29.70MM |
| Operating Income | $-29.70MM |
| Non-Operating Income | $0.84MM |
| R&D Expense | $25,215.61MM |
| Income(Loss) | $-28.85MM |
| Profit(Loss)* | $28,796.49MM |
| Stockholders Equity | $16.85MM |
| Assets | $21.08MM |
| Operating Cash Flow | $-25,619.70MM |
| Financing Cash Flow | $34,600.12MM |
| Earnings Per Share** | $1,401.15 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.